• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We’re Reading: Global Pandemic Accord; New Abortion Initiatives; Cervical Cancer Increasing

News
Article

Meeting the 2024 deadline for an international agreement on pandemic response may not happen; the Biden administration announces measures to counter restrictive state laws on abortion; cervical cancer incidence declines as more women receive the human papillomavirus vaccine.

Concerns Over Impending Deadline for Global Pandemic Accord

Director-general of the World Health Organization, Tedros Adhanom Ghebreyesus, PhD, MSc, is voicing apprehension regarding the approaching deadline for a global pandemic accord, according to Reuters. Additionally, he emphasizes the complexities involved in reaching a consensus on an international framework for pandemic response in 2024. This new pact and a series of updates to existing rules pertaining to pandemics are intended to be a comprehensive international agreement to shore up the world’s defenses against new pathogens after the COVID-19 pandemic.

Biden Administration Unveils New Abortion Initiatives on Roe v Wade Anniversary

On the anniversary of the Roe v Wade decision, the Biden administration has introduced a series of new initiatives aimed at supporting and protecting abortion rights, according to NBC News. President Biden's announcement came in response to the increasing challenges posed by restrictive state laws, reaffirming the administration's commitment to upholding reproductive rights. The initiatives signal a proactive approach to safeguarding access to abortion services and addressing the ongoing legal battles surrounding reproductive health care.

Cervical Cancer Increasing in Women Despite HPV Vaccine

New research suggests a positive correlation between the widespread administration of the human papillomavirus (HPV) vaccine and a significant decrease in cervical cancer cases among women, with rates falling fastest in women in their 20s, according to NBC News. However, cervical cancer incidence has been increasing in women in their 30s and early 40s, suggesting that not all women are similarly benefitting. As more individuals receive the vaccine, this development underscores the potential for further progress in preventing cervical cancer and related health complications.

Related Videos
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
Michael Morse, MD, Duke Cancer Center
Dr Chris Pagnani
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Inma Hernandez, PharmD, PhD, professor at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences
Binod Dhakal, MD
Screenshot of Joshua Meeks, MD, PhD, during a video interview
Screenshot of Yuzhi Wang, MD, in a video interview
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.